Advances in developing novel therapeutic strategies for Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Authors
Keywords
Alzheimer’s disease, Novel therapies, Pre-clinical and clinical trials, Drug development
Journal
Molecular Neurodegeneration
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-12
DOI
10.1186/s13024-018-0299-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia-Mediated Neuroprotection, TREM2 , and Alzheimer’s Disease: Evidence From Optical Imaging
- (2018) Carlo Condello et al. BIOLOGICAL PSYCHIATRY
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
- (2018) Alireza Atri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
- (2018) Xiangyou Hu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy
- (2018) Sang-Won Min et al. JOURNAL OF NEUROSCIENCE
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
- (2018) Chengzhong Wang et al. NATURE MEDICINE
- Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection
- (2018) William A. Eimer et al. NEURON
- Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus
- (2018) Ben Readhead et al. NEURON
- Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease
- (2018) Jennifer N.K. Nyarko et al. NEUROSCIENCE
- Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics
- (2018) Jan Verheijen et al. TRENDS IN GENETICS
- Tau Antibody Structure Reveals a Molecular Switch Defining a Pathological Conformation of the Tau Protein
- (2018) Jessica E. Chukwu et al. Scientific Reports
- Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
- (2018) Chun-ling Dai et al. Alzheimers Research & Therapy
- Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease
- (2018) Michael S. Rafii et al. JAMA Neurology
- Blocking the Apolipoprotein E/Amyloid-β Interaction Reduces Fibrillar Vascular Amyloid Deposition and Cerebral Microhemorrhages in TgSwDI Mice
- (2018) Jing Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- The Many Substrates of Presenilin/γ-Secretase
- (2018) Annakaisa Haapasalo et al. JOURNAL OF ALZHEIMERS DISEASE
- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- Paradoxical Effect of TrkA Inhibition in Alzheimer's Disease Models
- (2018) Qiang Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- Small Molecule p75NTR Ligands Reduce Pathological Phosphorylation and Misfolding of Tau, Inflammatory Changes, Cholinergic Degeneration, and Cognitive Deficits in AβPPL/S Transgenic Mice
- (2018) Thuy-Vi V. Nguyen et al. JOURNAL OF ALZHEIMERS DISEASE
- A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia1
- (2018) George M. Haig et al. JOURNAL OF ALZHEIMERS DISEASE
- The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
- (2018) Stina Tucker et al. JOURNAL OF ALZHEIMERS DISEASE
- Author Correction: Gamma frequency entrainment attenuates amyloid load and modifies microglia
- (2018) Hannah F. Iaccarino et al. NATURE
- Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load
- (2018) Annabelle C. Singer et al. Nature Protocols
- Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
- (2017) Jos Prickaerts et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
- (2017) Charbel E-H. Moussa EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
- (2017) Francis T. Hane et al. JOURNAL OF ALZHEIMERS DISEASE
- Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
- (2017) Sergey O. Bachurin et al. MEDICINAL RESEARCH REVIEWS
- Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer’s Disease
- (2017) Alan López-López et al. MOLECULAR NEUROBIOLOGY
- Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae
- (2017) Onder Albayram et al. Nature Communications
- Tau passive immunization inhibits not only tau but also Aβ pathology
- (2017) Chun-ling Dai et al. Alzheimers Research & Therapy
- Propagation of Tau aggregates
- (2017) Michel Goedert et al. Molecular Brain
- Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
- (2017) Mark A. Reger et al. JOURNAL OF ALZHEIMERS DISEASE
- p70 S6 Kinase and Tau in Alzheimer's Disease
- (2017) Jin-Jing Pei et al. JOURNAL OF ALZHEIMERS DISEASE
- Reductions in Amyloid-β-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation
- (2017) Anna Parachikova et al. JOURNAL OF ALZHEIMERS DISEASE
- A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy
- (2017) Hanna Trzeciakiewicz et al. Scientific Reports
- Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
- (2017) Hameetha Rajamohamedsait et al. Scientific Reports
- Apolipoprotein E as a Therapeutic Target in Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2016) Yu Yamazaki et al. CNS DRUGS
- Neuroprotective Mechanisms Mediated by CDK5 Inhibition
- (2016) Gohar Mushtaq et al. CURRENT PHARMACEUTICAL DESIGN
- Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
- (2016) Lidia Bakota et al. DRUGS
- Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1
- (2016) Masaya Tachibana et al. EXPERIMENTAL NEUROLOGY
- Two Phase 2 Multiple Ascending–Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer’s Disease
- (2016) Florence Pasquier et al. JOURNAL OF ALZHEIMERS DISEASE
- Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease
- (2016) Puneet Talwar et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment
- (2016) Peter Dongmin Sohn et al. Molecular Neurodegeneration
- Gamma frequency entrainment attenuates amyloid load and modifies microglia
- (2016) Hannah F. Iaccarino et al. NATURE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss
- (2016) Tara E. Tracy et al. NEURON
- Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8
- (2016) Thomas J. Malia et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease
- (2016) Deepak Kumar Vijaya Kumar et al. Science Translational Medicine
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
- (2016) Francesco Panza et al. Biomed Research International
- Potential of the Antibody Against cis–Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury
- (2016) Kun Ping Lu et al. JAMA Neurology
- Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
- (2016) Jaume Folch et al. NEURAL PLASTICITY
- MIND diet associated with reduced incidence of Alzheimer's disease
- (2015) Martha Clare Morris et al. Alzheimers & Dementia
- MIND diet slows cognitive decline with aging
- (2015) Martha Clare Morris et al. Alzheimers & Dementia
- Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
- (2015) Adam C. Kaufman et al. ANNALS OF NEUROLOGY
- AZD8797 is an allosteric non-competitive modulator of the human CX3CR1 receptor
- (2015) L. Cederblad et al. BIOCHEMICAL JOURNAL
- No Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes
- (2015) Weitao Zhou et al. Current Alzheimer Research
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence
- (2015) Jacob S. Buckley et al. DRUGS & AGING
- The genetic landscape of Alzheimer disease: clinical implications and perspectives
- (2015) Caroline Van Cauwenberghe et al. GENETICS IN MEDICINE
- Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice
- (2015) Rebecca Skerrett et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease
- (2015) B. T. Casali et al. JOURNAL OF NEUROSCIENCE
- The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central A Pharmacodynamic Responses in Mice, Dogs, and Humans
- (2015) P. C. May et al. JOURNAL OF NEUROSCIENCE
- E-pharmacophore-based virtual screening to identify GSK-3β inhibitors
- (2015) Pradeep Natarajan et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial
- (2015) Tiia Ngandu et al. LANCET
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay
- (2015) Wendy E. Heywood et al. Molecular Neurodegeneration
- Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
- (2015) Jin Hu et al. Molecular Neurodegeneration
- Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
- (2015) Asami Kondo et al. NATURE
- Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
- (2015) Sang-Won Min et al. NATURE MEDICINE
- Invited review: Drug development for tauopathies
- (2015) Fiona Grüninger NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer’s disease pathogenesis
- (2015) Li Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of TGFβ signaling in the pathogenesis of Alzheimer’s disease
- (2015) Rommy von Bernhardi et al. Frontiers in Cellular Neuroscience
- Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease
- (2015) María José Pérez et al. PPAR Research
- Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
- (2015) Carlo Condello et al. Nature Communications
- A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
- (2015) Haakon B Nygaard et al. Alzheimers Research & Therapy
- Nerve Growth Factor Gene Therapy
- (2015) Mark H. Tuszynski et al. JAMA Neurology
- A Reduced Astrocyte Response to β-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment
- (2015) Ryan Mathur et al. PLoS One
- Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
- (2014) Eduardo Martínez-Morillo et al. ACTA NEUROPATHOLOGICA
- A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
- (2014) Michael S. Rafii et al. Alzheimers & Dementia
- Sex modifies theAPOE-related risk of developing Alzheimer disease
- (2014) Andre Altmann et al. ANNALS OF NEUROLOGY
- A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H3 Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease
- (2014) Richard Grove et al. Current Alzheimer Research
- Dimebon Attenuates the Aβ-Induced Mitochondrial Permeabilization
- (2014) Elena Shevtsova et al. Current Alzheimer Research
- The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease
- (2014) Angela Hanson et al. CURRENT PHARMACEUTICAL DESIGN
- Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
- (2014) M. Yarchoan et al. DIABETES
- Multifunctional compounds: Smart molecules for multifactorial diseases
- (2014) Yogita Bansal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Amyloid-directed monoclonal antibodies for the treatment of Alzheimer’s disease: the point of no return?
- (2014) Francesco Panza et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
- (2014) William James Deardorff et al. Expert Review of Neurotherapeutics
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease
- (2014) Maurice W. Dysken et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid-β Pathology andAPOEGenotype Modulate Retinoid X Receptor Agonist Activityin Vivo
- (2014) Leon M. Tai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies
- (2014) Chun-ling Dai et al. JOURNAL OF NEURAL TRANSMISSION
- Reversal of apoE4-Driven Brain Pathology and Behavioral Deficits by Bexarotene
- (2014) A. Boehm-Cagan et al. JOURNAL OF NEUROSCIENCE
- Anti-ApoE Antibody Given after Plaque Onset Decreases A Accumulation and Improves Brain Function in a Mouse Model of A Amyloidosis
- (2014) F. Liao et al. JOURNAL OF NEUROSCIENCE
- Ten-Year Effects of the Advanced Cognitive Training for Independent and Vital Elderly Cognitive Training Trial on Cognition and Everyday Functioning in Older Adults
- (2014) George W. Rebok et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial
- (2014) David Wilkinson et al. LANCET NEUROLOGY
- Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
- (2014) Sam Norton et al. LANCET NEUROLOGY
- Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk
- (2014) Leon M Tai et al. Molecular Neurodegeneration
- Microglial priming in neurodegenerative disease
- (2014) V. Hugh Perry et al. Nature Reviews Neurology
- Insulin resistance in Alzheimer's disease
- (2014) Kelly T. Dineley et al. NEUROBIOLOGY OF DISEASE
- ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?
- (2014) Takahisa Kanekiyo et al. NEURON
- Phase 3 Trials of Solanezumab and Bapineuzumab for Alzheimer's Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
- (2014) Masafumi Ihara et al. PLoS One
- A Small Molecule p75NTR Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression
- (2014) Danielle A. Simmons et al. PLoS One
- Fyn kinase inhibition as a novel therapy for Alzheimer’s disease
- (2014) Haakon B Nygaard et al. Alzheimers Research & Therapy
- Active immunotherapy options for Alzheimer’s disease
- (2014) Bengt Winblad et al. Alzheimers Research & Therapy
- Immunogenicity of DNA- and recombinant protein-based Alzheimer Disease epitope vaccines
- (2014) Hayk Davtyan et al. Human Vaccines & Immunotherapeutics
- Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function
- (2014) Angel C. Y. Mak et al. JAMA Neurology
- Microglia actions in Alzheimer’s disease
- (2013) Stefan Prokop et al. ACTA NEUROPATHOLOGICA
- Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data
- (2013) Maurice W. Dysken et al. Alzheimers & Dementia
- Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration
- (2013) Magdalena A. Kuszczyk et al. AMERICAN JOURNAL OF PATHOLOGY
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2013) Jessica Freiherr et al. CNS DRUGS
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- Review article What causes alzheimer’s disease?
- (2013) Richard A. Armstrong FOLIA NEUROPATHOLOGICA
- Levels of Soluble Apolipoprotein E/Amyloid-β (Aβ) Complex Are Reduced and Oligomeric Aβ Increased withAPOE4and Alzheimer Disease in a Transgenic Mouse Model and Human Samples
- (2013) Leon M. Tai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
- (2013) Shan Liu et al. JOURNAL OF NEUROCHEMISTRY
- Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury
- (2013) C. Tep et al. JOURNAL OF NEUROSCIENCE
- A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease
- (2013) D. A. Simmons et al. JOURNAL OF NEUROSCIENCE
- Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice
- (2013) Katherine D LaClair et al. Molecular Neurodegeneration
- Tau immunotherapy targets transcellular propagation
- (2013) Monica Hoyos Flight NATURE REVIEWS DRUG DISCOVERY
- Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease
- (2013) Frank M. Longo et al. NATURE REVIEWS DRUG DISCOVERY
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model
- (2013) Juliet K. Knowles et al. NEUROBIOLOGY OF AGING
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- 7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease
- (2013) Zhentao Zhang et al. NEUROPSYCHOPHARMACOLOGY
- Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease
- (2013) Nicholas Kozauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease
- (2013) Ji Won Um et al. Prion
- Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis
- (2013) Akihiko Taguchi et al. Psychogeriatrics
- Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain
- (2013) E. Hudry et al. Science Translational Medicine
- Recent developments of protein kinase inhibitors as potential AD therapeutics
- (2013) Volkmar Tell et al. Frontiers in Cellular Neuroscience
- Complexity of Receptor Tyrosine Kinase Signal Processing
- (2013) N. Volinsky et al. Cold Spring Harbor Perspectives in Biology
- Presenilins and -Secretase: Structure, Function, and Role in Alzheimer Disease
- (2013) B. De Strooper et al. Cold Spring Harbor Perspectives in Medicine
- Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
- (2013) Angela J. Hanson et al. JAMA Neurology
- Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases
- (2013) P R Bharadwaj et al. Translational Psychiatry
- Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
- (2013) Moussa B.H. Youdim Experimental Neurobiology
- Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
- (2012) Ana García-Osta et al. ACS Chemical Neuroscience
- Comparison of Three Amyloid Assembly Inhibitors: The Sugar scyllo-Inositol, the Polyphenol Epigallocatechin Gallate, and the Molecular Tweezer CLR01
- (2012) Sharmistha Sinha et al. ACS Chemical Neuroscience
- 2012 Alzheimer’s disease facts and figures
- (2012) Alzheimers & Dementia
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
- (2012) Orly Weinreb et al. CURRENT DRUG TARGETS
- The role of astrocytes in amyloid β-protein toxicity and clearance
- (2012) Dietmar Rudolf Thal EXPERIMENTAL NEUROLOGY
- Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms
- (2012) Jie Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
- (2012) Katherine L. Youmans et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Trans-cellular Propagation of Tau Aggregation by Fibrillar Species
- (2012) Najla Kfoury et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
- (2012) Jungsu Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
- (2012) Maria L Maccecchini et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- A TrkB Small Molecule Partial Agonist Rescues TrkB Phosphorylation Deficits and Improves Respiratory Function in a Mouse Model of Rett Syndrome
- (2012) D. A. Schmid et al. JOURNAL OF NEUROSCIENCE
- Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial
- (2012) Bruno Vellas et al. LANCET NEUROLOGY
- Total ApoE and ApoE4 Isoform Assays in an Alzheimer's Disease Case-control Study by Targeted Mass Spectrometry (n= 669): A Pilot Assay for Methionine-containing Proteotypic Peptides
- (2012) Romain Simon et al. MOLECULAR & CELLULAR PROTEOMICS
- Neuroinflammatory phenotype in early Alzheimer's disease
- (2012) Tiffany L. Sudduth et al. NEUROBIOLOGY OF AGING
- GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia
- (2012) Holly F. Green et al. NEUROCHEMISTRY INTERNATIONAL
- APOE-Mimetic Peptides Reduce Behavioral Deficits, Plaques and Tangles in Alzheimers Disease Transgenics
- (2012) M.P. Vitek et al. Neurodegenerative Diseases
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Erratum: Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity
- (2012) D Scarpi et al. Cell Death & Disease
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
- (2011) Gerald W. Hart et al. Annual Review of Biochemistry
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Combination Therapy for Alzheimerʼs Disease
- (2011) Laxeshkumar Patel et al. DRUGS & AGING
- Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons
- (2011) Hung-Kai Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure-dependent Impairment of Intracellular Apolipoprotein E4 Trafficking and Its Detrimental Effects Are Rescued by Small-molecule Structure Correctors
- (2011) Jens Brodbeck et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PKC Activation Prevents Synaptic Loss, A Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice
- (2011) J. Hongpaisan et al. JOURNAL OF NEUROSCIENCE
- Robust Amyloid Clearance in a Mouse Model of Alzheimer's Disease Provides Novel Insights into the Mechanism of Amyloid- Immunotherapy
- (2011) A. Wang et al. JOURNAL OF NEUROSCIENCE
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy
- (2011) Lenore J Launer et al. LANCET NEUROLOGY
- Mapping ApoE/Aβ binding regions to guide inhibitor discovery
- (2011) Qian Liu et al. Molecular BioSystems
- Ligand-Dependent TrkA Activity in Brain Differentially Affects Spatial Learning and Long-Term Memory
- (2011) T. Aboulkassim et al. MOLECULAR PHARMACOLOGY
- The apoE-mimetic Peptide, COG1410, Improves Functional Recovery in a Murine Model of Intracerebral Hemorrhage
- (2011) Daniel T. Laskowitz et al. Neurocritical Care
- 7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease
- (2011) Latha Devi et al. NEUROPSYCHOPHARMACOLOGY
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Human apoE Isoforms Differentially Regulate Brain Amyloid- Peptide Clearance
- (2011) J. M. Castellano et al. Science Translational Medicine
- Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline
- (2010) Karin Yurko-Mauro et al. Alzheimers & Dementia
- CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models
- (2010) Sungho Lee et al. AMERICAN JOURNAL OF PATHOLOGY
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice
- (2010) James J. Donkin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Liver X Receptor Agonist Treatment Ameliorates Amyloid Pathology and Memory Deficits Caused by High-Fat Diet in APP23 Mice
- (2010) N. F. Fitz et al. JOURNAL OF NEUROSCIENCE
- CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid- Phagocytosis
- (2010) Z. Liu et al. JOURNAL OF NEUROSCIENCE
- Regulation of Tau Pathology by the Microglial Fractalkine Receptor
- (2010) Kiran Bhaskar et al. NEURON
- Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
- (2010) Luis Escribano et al. NEUROPSYCHOPHARMACOLOGY
- A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
- (2010) S.-W. Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor
- (2010) Kevin W. Gillman et al. ACS Medicinal Chemistry Letters
- Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
- (2010) Claire J. Garwood et al. Frontiers in Psychiatry
- A Combination Therapy of Donepezil and Cilostazol for Patients With Moderate Alzheimer Disease: Pilot Follow-Up Study
- (2009) Heii Arai et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
- (2009) F. Liu et al. BRAIN
- Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
- (2009) Morten Thomsen et al. CURRENT PHARMACEUTICAL DESIGN
- Adherence to a Mediterranean Diet, Cognitive Decline, and Risk of Dementia
- (2009) Catherine Féart JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Physical Activity, Diet, and Risk of Alzheimer Disease
- (2009) Nikolaos Scarmeas JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can Lithium or Valproate Untie Tangles in Alzheimer's Disease?
- (2009) Pierre N. Tariot et al. JOURNAL OF CLINICAL PSYCHIATRY
- Lithium Trial in Alzheimer's Disease
- (2009) Harald Hampel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Nerve Growth Factor and Neurotrophin-3 Mediate Survival of Pulmonary Plasma Cells during the Allergic Airway Inflammation
- (2009) M. Abram et al. JOURNAL OF IMMUNOLOGY
- Divergent Pathways Mediate Spine Alterations and Cell Death Induced by Amyloid- , Wild-Type Tau, and R406W Tau
- (2009) C. Tackenberg et al. JOURNAL OF NEUROSCIENCE
- Liver X receptor activation restores memory in aged AD mice without reducing amyloid
- (2009) Tim Vanmierlo et al. NEUROBIOLOGY OF AGING
- A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
- (2009) L. Serenó et al. NEUROBIOLOGY OF DISEASE
- Systemic inflammation and disease progression in Alzheimer disease
- (2009) C. Holmes et al. NEUROLOGY
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
- (2009) Jungsu Kim et al. NEURON
- Apolipoprotein E4 domain interaction: Synaptic and cognitive deficits in mice
- (2008) Ning Zhong et al. Alzheimers & Dementia
- Activation of Fyn tyrosine kinase in the mouse dorsal hippocampus is essential for contextual fear conditioning
- (2008) Tomoko Isosaka et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The neuroprotective mechanism of action of the multimodal drug ladostigil
- (2008) Orly Weinreb Frontiers in Bioscience-Landmark
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled Trial
- (2008) Steven T. DeKosky JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease
- (2008) Nicola T. Lautenschlager et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Understanding the Association of Apolipoprotein E4 with Alzheimer Disease: Clues from Its Structure
- (2008) Ning Zhong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of the design differences between the Ginkgo Evaluation of Memory study and the Guidage study
- (2008) J. D. Williamson et al. Journal of Nutrition Health & Aging
- Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs
- (2008) Ana Martinez MEDICINAL RESEARCH REVIEWS
- Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing
- (2008) Yi Wen et al. NEURON
- ApoE Promotes the Proteolytic Degradation of Aβ
- (2008) Qingguang Jiang et al. NEURON
- Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
- (2003) H. F. Dovey et al. JOURNAL OF NEUROCHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now